Enhanced Group CEO: Hot peptide summer is coming — but likely not till 2027

<p>Thanks to our partner:Superpower - https://superpower.com</p><p><br></p><p>Max&#39;s recent essays on peptides:</p><p>https://maximilianbmartin.substack.com/p/six-peptides-one-signal-washington</p><p>https://maximilianbmartin.substack.com/p/the-peptide-moment-is-here-enhanced</p><p><br></p><p>In episode 76 of Hims House, Jonathan Stern hosts Maximilian Martin, CEO of Enhanced Group ( $ENHA ), the newly public company behind the Enhanced Games and the Live Enhanced telehealth platform. Martin grades the inaugural games ten weeks out — 42 athletes, 21 personal bests, one world record, and $32M in contracted sponsorship — and argues the 40% stock price selloff that occurred after the Games is misplaced. He recounts his week in Washington D.C., around the FDA compounding advisory committee, where six of seven peptides were recommended, and explains why Enhanced will wait on FDA’s formal rulemaking to start selling peptides. He concedes peptides are essentially a “commodity”, so the edge has to come from brand and personalized protocols. Also covered: whether big pharma is quietly slowing things down, how big the market for peptides could be, and Enhanced’s recent supplements launch in 33 new countries. </p><p><br></p><p>00:00 - Sponsor: Superpower 
</p><p>01:38 - The Enhanced Games: an honest scorecard
</p><p>06:35 - Why $ENHA stock fell 40%
</p><p>10:13 - The athlete-led flywheel
</p><p>11:52 - Why he flew to Washington for peptides
</p><p>18:07 - Six of seven peptides recommended
</p><p>20:21 - How long will FDA rulemaking take? 
</p><p>22:51 - Where the peptide moat actually is
</p><p>30:16 - Is big pharma slowing down peptide approval?</p><p>32:14 - Being first vs being best
</p><p>40:33 - Could peptides be a $10B market in 2027? 
</p><p>46:00 - Enhanced now live in 33 new markets
</p><p>50:25 - Life as a public company CEO</p><p><br></p><p>Disclaimer: This podcast is for informational and entertainment purposes only. Nothing discussed should be considered financial, investment, or legal advice. Always consult with a qualified professional before making financial decisions.</p>